Mercedes Gironella Mesa

9PUBLICATIONS
57CO-AUTHORS
Medical genetics (excl. cancer genetics)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 25, 2026
Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes.

|Apr 25, 2025
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy.

Andrea Manubens, Bruno Paiva, Norma C Gutiérrez

|Oct 26, 2024
Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study.

Felipe de Arriba de la Fuente, Mercedes Gironella Mesa, Miguel Teodoro Hernández García

|Oct 21, 2024
Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.

Rakesh Popat, Bradley Augustson, Mercedes Gironella

|May 08, 2023
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV-2 booster vaccination in hematologic neoplasms.

Moraima Jiménez, Candela Fernández-Naval, Víctor Navarro

|Mar 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.

Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig

Pageof 2

Frequent Collaborators

3 joint publications

Maria-Victoria Mateos

2 joint publications

Felipe de Arriba de la Fuente

2 joint publications

Joaquín Martínez-López

2 joint publications

Laura Rosiñol